Longitudinal changes during aging using proton magnetic resonance spectroscopy

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 61, Issue 3, 2006, Pages 291-298

  Ross, Amy J ^a,b   Sachdev, Perminder S ^a,b   Wen, Wei ^b   Brodaty, Henry ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATININE; INOSITOL; N ACETYLASPARTIC ACID;

AGED; AGING; ARTICLE; COGNITION; CORRELATION ANALYSIS; EDUCATION; FEMALE; GERIATRIC DEPRESSION SCALE; GRAY MATTER; HUMAN; LONGITUDINAL STUDY; MALE; METABOLITE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

EID: 33645976139     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/61.3.291     Document Type: Article

References (55)

1. Resnick SM, Pham DL, Kraut MA, Zonderman AB, Davatzikos C. Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J Neurosci. 2003;23:3295-3301.
2. Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, Fox NC. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol. 2003;60:989-994.
3. Tisserand DJ, van Boxtel MP, Pruessner JC, Hofman P, Evans AC, Jolles J. A voxel-based morphometric study to determine individual differences in gray matter density associated with age and cognitive change over time. Cereb Cortex. 2004;14:966-973.
4. Cook IA, Leuchter AF, Morgan ML, et al. Longitudinal progression of subclinical structural brain disease in normal aging. Am J Geriatr Psychiatry. 2004;12:190-200.
5. Davatzikos C, Resnick SM. Degenerative age changes in white matter connectivity visualized in vivo using magnetic resonance imaging. Cereb Cortex. 2002;12:767-771.
6. Bates TE, Strangward M, Keelan J, Davey GP, Munro PM, Clark JB. Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport. 1996;7:1397-1400.
7. Valenzuela MJ, Sachdev P. Magnetic resonance spectroscopy in AD. Neurology. 2001;56:592-598.
8. Ross AJ, Sachdev PS. Magnetic resonance spectroscopy in cognitive research. Brain Res Rev. 2004;44:83-102.
9. Brooks JCW, Roberts N, Kemp GJ, Gosney MA, Lye M, Whitehouse GH. A proton magnetic resonances spectroscopy study of age-related changes in frontal lobe metabolite concentrations. Cereb Cortex. 2001;11:598-605.
10. Uno M, Harada M, Nagahiro S. Quantitative evaluation of cerebral metabolites and cerebral blood flow in patients with carotid stenosis. Neurol Res. 2001;23:573-580.
11. Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO. In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging. Magn Reson Med. 1999;41:276-284.
12. Chang L, Ernst T, Poland RE, Jenden DJ. In vivo proton magnetic resonance spectroscopy of the normal aging human brain. Life Sci. 1996;58:2049-2056.
13. Harada M, Miyoshi H, Otsuka H, Nishitani H, Uno M. Multivariate analysis of regional metabolic differences in normal ageing on localised quantitative proton MR spectroscopy. Neuroradiology. 2001;43:448-452.
14. Leary SM, Brex PA, MacManus DG, et al. A (1)H magnetic resonance spectroscopy study of aging in parietal white matter: implications for trials in multiple sclerosis. Magn Reson Imaging. 2000;18:455-459.
15. Sober BJ, van Zijl PC, Duyn JH, Barker PB. Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med. 1996;35:356-363.
16. Sijens PE, Oudkerk M, de Leeuw FE, et al. 1H chemical shift imaging of the human brain at age 60-90 years reveals metabolic differences between women and men. Magn Reson Med. 1999;42:24-31.
17. Schuff N, Amend DL, Knowlton R, Norman D, Fein G, Weiner MW. Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging. Neurobiol Aging. 1999;20:279-285.
18. Marshall I, Wardlaw J, Cannon J, Slattery J, Sellar RJ. Reproducibility of metabolite peak areas in 1H MRS of brain. Magn Reson Imaging. 1996;14:281-292.
19. Dixon RM, Bradley KM, Budge MM, Styles P, Smith AD. Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. Brain. 2002;125:2332-2341.
20. Narayana PA, Johnston D, Flamig DP. In vivo proton magnetic resonance spectroscopy studies of human brain. Magn Reson Imaging. 1991;9:303-308.
21. Cohen BM, Renshaw PF, Stoll AL, Wurtman RJ, Yurgelun-Todd D, Babb SM. Decreased brain choline uptake in older adults. An in vivo proton magnetic resonance spectroscopy study. JAMA. 1995;274:902-907.
22. Kadota T, Horinouchi T, Kuroda C. Development and aging of the cerebrum: assessment with proton MR spectroscopy. Ajnr: Am J Neuroradiol. 2001;22:128-135.
23. Small SA, Stern Y, Tang M, Mayeux R. Selective decline in memory function among healthy elderly. Neurology. 1999;52:1392-1396.
24. West RL. An application of prefrontal cortex function theory to cognitive aging. Psychol Bull. 1996;120:272-292.
25. Sachdev PS, Brodaty H, Valenzuela MJ, et al. The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients. Neurology. 2004;62:912-919.
26. Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989;19:1015-1022.
27. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York: The Psychological Corporation; 1981.
28. Wechsler D. Wechsler Memory Scale-Revised. New York: The Psychological Corporation; 1987.
29. Weiss U, Bacher R, Vonbank H, Kemmler G, Lingg A, Marksteiner J. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy. J Clin Psychiatry. 2003;64:235-242.
30. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery. Tucson, AZ: Neuropsychology Press; 1985.
31. Benton AL, Hamsher KD. Multilingual Aphasia Examination Manual. Iowa City: University of Iowa; 1978.
32. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39:1159-1165.
33. Mack WJ, Freed DM, Williams BW, Henderson VW. Boston Naming Test: shortened versions for use in Alzheimer's disease. J Gerontol. 1992;47:154-158.
34. Kertesz AED. Western Aphasia Battery. San Antonio, TX: The Psychological Corporation; 1983.
35. Benton AL, Hamsher Kd, Varney NR, Spreen O. Contributions to Neuropsychological Assessment. New York: Oxford University Press; 1983.
36. Smith A. Symbol Digit Modalities Test. Los Angeles: Western Psychological Services; 1991.
37. van den Boogaart A. MRUI MANUALV. 96,3. A User's Guide to the Magnetic Resonance User Interface Software Package. Delft: Delft Technical University Press; 1997.
38. Michaelis T, Merboldt KD, Bruhn H, Hanicke W, Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology. 1993;187:219-227.
39. Rose SE, de Zubicaray GI, Wang D, et al. A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. Magn Reson Imaging. 1999;17:291-299.
40. Dixon RM, Bradley KM, Budge MM, Styles P, Smith AD. Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. Brain. 2002;125:2332-2341.
41. Ross BD, Bluml S, Cowan R, Danielsen E, Farrow N, Gruetter R. In vivo magnetic resonance spectroscopy of human brain: the biophysical basis of dementia. Biophys Chem. 1997;68:161-172.
42. Fisher SK, Novak JE, Agranoff BW. Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem. 2002;82:736-754.
43. Kantarci K, Jack CR Jr, Xu YC, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study. Neurology. 2000;55:210-217.
44. Braak H, Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurolog Scand Suppl. 1996;165:3-12.
45. Huang W, Alexander GE, Daly EM, et al. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. Am J Psychiatry. 1999;156:1879-1866.
46. Komoroski RA, Heimberg C, Cardwell D, Karson CN. Effects of gender and region on proton MRS of normal human brain. Magn Reson Imaging. 1999;17:427-433.
47. Saunders DE, Howe FA, van den BA, Griffiths JR, Brown MM. Aging of the adult human brain: in vivo quantitation of metabolite content with proton magnetic resonance spectroscopy. J Magn Reson Imaging. 1999;9:711-716.
48. Angelie E, Bonmartin A, Boudraa A, Gonnaud PM, Mallet JJ, Sappey-Marinier D. Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study. Ajnr: Am J Neuroradiol. 2001;22:119-127.
49. Charles HC, Lazeyras F, Krishnan KR, et al. Proton spectroscopy of human brain: effects of age and sex. Prog Neuro-Pyschopharmacol Biol Psychiatry. 1994;18:995-1004.
50. Gur RC, Mozley LH, Mozley PD, et al. Sex differences in regional cerebral glucose metabolism during a resting state. Science. 1995;267:528-531.
51. Murphy DG, DeCarli C, McIntosh AR, et al. Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch Gen Psychiatry. 1996;53:585-594.
52. Valenzuela MJ, Sachdev PS, Wen W, Shnier R, Brodaty H, Gillies D. Dual voxel proton magnetic resonance spectroscopy in the healthy elderly: subcortical-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changes. Neuroimage. 2000;12:747-756.
53. Robertson DMW, Van Amelsvoort T, Daly E, et al. Effects of estrogen replacement therapy on human brain aging: an in vivo 1H MRS study. Neurology. 2001;11:2114-2117.
54. Brooks WM, Friedman SD, Stidley CA. Reproducibility of 1H-MRS in vivo. Magn Reson Med. 1999;41:193-197.
55. Schirmer T, Auer DP. On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain. NMR Biomed. 2000;13:28-36.